Published in

Textbook of Diabetes, p. 187-204

DOI: 10.1002/9781118924853.ch14

Elsevier, Biochemical and Biophysical Research Communications, 2(452), p. 213-220

DOI: 10.1016/j.bbrc.2014.08.012

Nature Research, Nature, 7614(536), p. 41-47, 2016

DOI: 10.1038/nature18642

Links

Tools

Export citation

Search in Google Scholar

Genetic Architecture of Type 2 Diabetes

Journal article published in 2016 by Christian Fuchsberger, Tanya M. Teslovich, Xueling Sim, Juan Fernandez Tajes, Martijn van de Bunt, Heather M. Stringham, Michael L. Stitzel, Tibor V. Varga, Xu Wang, Ryan P. Welch, Joon Yoon, Weihua Zhang, Benjamin F. Voight, Alena Stančáková, Joshua D. Smith and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

The genetic architecture of common traits, including the number, frequency, and effect sizes of inherited variants that contribute to individual risk, has been long debated. Genome-wide association studies have identified scores of common variants associated with type 2 diabetes, but in aggregate, these explain only a fraction of the heritability of this disease. Here, to test the hypothesis that lower-frequency variants explain much of the remainder, the GoT2D and T2D-GENES consortia performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing in 12,940 individuals from five ancestry groups. To increase statistical power, we expanded the sample size via genotyping and imputation in a further 111,548 subjects. Variants associated with type 2 diabetes after sequencing were overwhelmingly common and most fell within regions previously identified by genome-wide association studies. Comprehensive enumeration of sequence variation is necessary to identify functional alleles that provide important clues to disease pathophysiology, but large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes.